Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Skinvisible (SKVI) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Skinvisible (SKVI) over the last 17 years, with Q3 2025 value amounting to $4.8 million.

  • Skinvisible's Total Current Liabilities rose 262.58% to $4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 million, marking a year-over-year increase of 262.58%. This contributed to the annual value of $3.7 million for FY2024, which is 412.42% up from last year.
  • Skinvisible's Total Current Liabilities amounted to $4.8 million in Q3 2025, which was up 262.58% from $4.5 million recorded in Q2 2025.
  • In the past 5 years, Skinvisible's Total Current Liabilities ranged from a high of $4.8 million in Q3 2025 and a low of $2.7 million during Q1 2023
  • In the last 5 years, Skinvisible's Total Current Liabilities had a median value of $3.5 million in 2023 and averaged $3.6 million.
  • In the last 5 years, Skinvisible's Total Current Liabilities crashed by 1262.25% in 2023 and then soared by 5018.14% in 2024.
  • Over the past 5 years, Skinvisible's Total Current Liabilities (Quarter) stood at $3.1 million in 2021, then increased by 19.07% to $3.6 million in 2022, then dropped by 3.64% to $3.5 million in 2023, then increased by 4.12% to $3.7 million in 2024, then skyrocketed by 30.31% to $4.8 million in 2025.
  • Its Total Current Liabilities stands at $4.8 million for Q3 2025, versus $4.5 million for Q2 2025 and $4.3 million for Q1 2025.